BEIJING, April 25, 2024 /PRNewswire/ — Waterdrop Inc. (“Waterdrop”, the “Company” or “we”) (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the U.S. Securities and Exchange Commission (“SEC”) on April 25, 2024. The annual report can be accessed on the Company’s investor relations website at https://ir.waterdrop-inc.com as well as the SEC’s website at http://www.sec.gov.
The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders upon request. Requests should be directed to the Company’s IR Department at IR@shuidi-inc.com.
About Waterdrop Inc.
Waterdrop Inc. (NYSE: WDH) is a leading technology platform dedicated to insurance and healthcare service with a positive social impact. Founded in 2016, with the comprehensive coverage of Waterdrop Insurance Marketplace and Waterdrop Medical Crowdfunding, Waterdrop aims to bring insurance and healthcare service to billions through technology. For more information, please visit www.waterdrop-inc.com.
For investor inquiries, please contact:
Waterdrop Inc.
E-mail: IR@shuidi-inc.com
Blueshirt
In China
Mr. Eric Yuan
Phone: +86-1380-111-0739
E-mail: eric@blueshirtgroup.co
In US
Ms. Silvia Chen
Phone: +1-347-741-0843
Email: silvia@blueshirtgroup.co
SOURCE Waterdrop Inc.
MDP Completes Acquisition of Significant Ownership Position in NextGen Healthcare and Partners with Thoma Bravo…
New resource helps healthcare providers improve branded communication, ensure HIPAA compliance, and boost patient engagement…
TEMPE, Ariz., June 6, 2025 /PRNewswire/ -- Economic activity in the hospital subsector expanded in…
Open-source leader democratizes enterprise-grade secrets management for fastest-growing startups, Fortune 500 enterprises, and nation-states. SAN…
MIAMI, June 6, 2025 /PRNewswire/ -- Healthy Together, a leading provider of health and human…
Fifth expansion since 2020 reflects growing demand for advanced pharmaceutical analysis and development services. WEST…